Seek, Find, and Treat: Best Practices for Managing Patients with Transthyretin Amyloid Polyneuropathy (ATTR-PN)
October 29, 2025
In this program, experts Drs. Morie Gertz, Michelle Mauermann, Sami Khella, and Ronald Witteles will describe best practices for the diagnosis, treatment, and monitoring of disease progression in these patients.
CME 1.00 Credits In-Progress
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes
October 08, 2025
In this symposium, Chair Dr. Mathew Maurer, and faculty members Dr. Noel Dasgupta, Dr. Omar Abou Ezzeddine, and Dr. Frederick Ruberg, will explain best practices for screening and diagnosing ATTR-CM in patients with concomitant HF, describe the treatment landscape, and, through case presentation, discuss practical considerations in management.
CME 1.25 Credits In-Progress
Clinical Clues, Diagnostic Pearls, and a Changing Therapeutic Landscape: Optimizing the Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure
July 30, 2025
In this symposium, three experts in ATTRCM (Dr. Mathew Maurer, Dr. Sarah Cuddy, and Dr. Melissa Lyle) will explain best practices for identifying and diagnosing ATTR-CM in patients with concomitant HF, describe the evidence for current ATTR-CM therapies and, through case presentation, discuss practical considerations in management.
CME 1.00 Credits In-Progress
Managing Hyperkalemia in Heart Failure: Implementing Strategies to Reduce Patient Risk
July 29, 2025
In this symposium, attendees will be provided with best practices by a multidisciplinary faculty on the prevention of hyperkalemia, identification of patients at risk for hyperkalemia, the importance of maintaining HF patients on RAASis and preferably at target doses, recent clinical evidence with novel potassium binders, and strategies for effective communication with patients.
CME 1.00 Credits In-Progress
Best Practices for Managing Intracerebral Hemorrhage
May 20, 2025
In this symposium, experts in ICH management will discuss the clinical evidence for blood pressure control and DOAC reversal and provide illustrative case studies. Results of studies focusing on bundles of care will be summarized, and faculty members will provide insights for an adoption of this strategy to improve patient outcomes.
CME Credit Obtained Off Site
Addressing Challenges: Best Practices for DOAC Reversal in Intracranial Hemorrhage
October 30, 2024
In this symposium, an expert multidisciplinary faculty will provide insights into and interpretations of clinical data, and challenging cases will reinforce key elements of prudent management of major bleeding in patients taking DOACs and experiencing intracranial hemorrhage.
No Credit Available
Improving Outcomes of Patients With Transthyretin Amyloid Polyneuropathy (ATTR-PN)
October 14, 2024
In this program, ATTR-PN experts (chair Dr. Morie Gertz, and faculty members Dr. Amanda Peltier and Dr. Michelle Mauermann) will present, through lectures and “realworld” case studies, current evidence and best practices for management of ATTR-PN.
No Credit Available
Managing Worsening Heart Failure with Reduced Ejection Fraction: Strategies for Successful Outcomes
August 04, 2024
In this educational initiative, the current definition and clinical impact of WHF will be described, and principles of management explained.
No Credit Available
Anticoagulant Reversal in Stroke: Best Practices for Successful Outcomes
March 12, 2023
This program will focus on why clinicians must have a greater recognition of the risks and potential consequences of anticoagulant reversal in patients receiving anticoagulant therapies and the treatment algorithms for initiating reversal therapy in the diverse and expanding patient populations who use anticoagulants.
No Credit Available
Improving Pump Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Challenges and Opportunities
March 23, 2022
In this program, HF experts will provide insights into mechanisms and clinical evidence for improving myocardial contractility, and emphasize the need for a more personalized treatment of HFrEF to optimize patient outcomes.
No Credit Available
SGLT2 Inhibition and Heart Failure: Translating the Evidence to Clinical Practice
March 19, 2022
Information on best uses of SGLT2 inhibitors for patients with HF will be disseminated through lecture, interactive case presentation, panel discussion, and question-and-answer with experts.
No Credit Available
Keys to Prevention and Risk Reduction with Antiplatelet Therapy in Patients with Acute Ischemic Stroke and Transient Ischemic Attack
March 13, 2022
In this program, Chair Dr. S. Claiborne Johnston, Dr. Brett Cucchiara, Dr. Louise McCullough, and Dr. Carlos Molina will interpret the evidence for DAPT, provide insights into the choice of clopidogrel or ticagrelor to add to ASA, describe deficiencies in care preventing optimal use of DAPT, and explain remedies.
No Credit Available